OriGynMED raises $15.3m in Series B financing
The round was led by Sequoia Capital, with participation from its founding investor Eight Roads.

The proceeds will go towards ramping up its research and development (R&D) capabilities, business expansion, medical education, and marketing, as well as promotion and talent development.

Founded in 2015, OriGynMED provides overall solutions and cost-effective innovative products for healthcare niches. The company plans to launch a first gynecology innovative medical device product portfolio in 2021, and initiate a national clinical medical education and training program centered on minimally invasive gynecological surgery.

Share

The information on these pages is intended solely for the benefit of entrepreneurs and businesses seeking venture capital investment. Eight Roads does not offer and is not offering to provide investment advisory services nor is it offering to engage in any transactions in securities.